A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension
Clinical trial NCT00631917 · COMPLETED
Trial details
- NCT number
- NCT00631917
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-09-01
- Enrollment
- 774
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.